Get the full picture
Sign in to uncover key details.
Oxford Biomedical Technologies
Healthcare Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3555 Fiscal Ct Ste 9, Riviera Beach, Flo...Phone Number
(561) 848-7111Website
www.nowleap.comRevenue
<$5 MillionIndustry
About Oxford Biomedical Technologies
Oxford Biomedical Technologies is a leader in food sensitivity testing, therapy, training, and technology development, utilizing advanced proprietary instruments for their patented Mediator Release blood test (MRT). They provide innovative solutions for hidden inflammatory responses to foods and food chemicals, aiming to improve health outcomes for patients suffering from conditions like irritable bowel syndrome, migraines, and fibromyalgia. Their unique LEAP anti-inflammatory eating plan complements the MRT, offering quick and lasting relief from diet-induced inflammation. Targeting healthcare practitioners and patients, Oxford facilitates effective dietary therapy and personalized health solutions.Explore more
Oxford Biomedical Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Oxford Biomedical Technologies Tech Stack
A closer look at the technologies used by Oxford Biomedical Technologies
Top Healthcare Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Oxford Biomedical Technologies
Sign Up For FreeTo access detailed company insights
Oxford Biomedical Technologies is a leader in food sensitivity testing, therapy, training, and technology development, utilizing advanced proprietary instruments for their patented Mediator Release blood test (MRT). They provide innovative solutions for hidden inflammatory responses to foods and food chemicals, aiming to improve health outcomes for... Read More
